Inflammation and nutrition have been reported to be associated with cancer progression, drug response, and cancer survival. Many inflammatory or nutritional prognostic indices, including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), prognostic nutrition index (PNI), and albumin-to-globulin ratio (AGR), have been developed to predict survival outcomes in solid tumors [4]. The gene discussed is ALB; the disease is cancer.